MILESTONE Trademark

Trademark Overview

On Wednesday, April 3, 2019, a trademark application was filed for MILESTONE with the United States Patent and Trademark Office. The USPTO has given the MILESTONE trademark a serial number of 88370030. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 31, 2022. This trademark is owned by ACORDA THERAPEUTICS, INC.. The MILESTONE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

providing medical and scientific research information in the field of clinical trials for pharmaceutical and biological preparations used in the treatment of diseases, disorders and conditions of the nervous system
milestone

General Information

Serial Number88370030
Word MarkMILESTONE
Filing DateWednesday, April 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and Servicesproviding medical and scientific research information in the field of clinical trials for pharmaceutical and biological preparations used in the treatment of diseases, disorders and conditions of the nervous system

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 20, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACORDA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502
Party NameACORDA THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502

Trademark Events

Event DateEvent Description
Monday, January 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 20, 2021TTAB RELEASE CASE TO TRADEMARKS
Thursday, May 20, 2021OPPOSITION TERMINATED NO. 999999
Thursday, May 20, 2021OPPOSITION DISMISSED NO. 999999
Friday, June 19, 2020OPPOSITION INSTITUTED NO. 999999
Thursday, January 23, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 15, 2019ASSIGNED TO LIE
Thursday, November 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 20, 2019NON-FINAL ACTION E-MAILED
Monday, May 20, 2019NON-FINAL ACTION WRITTEN
Thursday, May 16, 2019ASSIGNED TO EXAMINER
Saturday, April 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 6, 2019NEW APPLICATION ENTERED

Related Keywords

milestone treatment used preparations diseases disorders system nervous conditions biological pharmaceutical